Skip to content

NRXP - NRX Pharmaceuticals, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchN

NRX Pharmaceuticals Inc

NRXP · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

N

NRXPNRX Pharmaceuticals Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $5.05
52-wk low: $1.62
Prev close: $3.43
Mkt cap: $144.2M
Fwd P/E: 34.3x
Beta: 2.18

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$9.0M

BA
Balyasny
Dmitry Balyasny · Q2 2026 13F
$3.7M
position
CI
Citadel
Ken Griffin · Q2 2026 13F

Earnings

Reported Aug 14, 2026

Earnings came in $0.09 a share below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Forward P/E: 34.25
Market cap: $144M

Valuation

P/S62.88
P/B2.90

Quality

Operating margin-444.6%

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: NRXP
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $144.18M
Beta: 2.18

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/S

62.9x

P/B

2.9x

Profit margin

+0.0%

Op margin

-444.6%

ROE

-683.0%

$2.8M

position

MW

Marshall Wace

Q2 2026 13F

$796K

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for NRXP

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.18-$0.09

-$0.09 expected

Next report

What the street expects next

EPS expected

-$0.08

-$0.08 to -$0.08

Revenue expected

$1.5M

3 analysts

Last 30 days

0up1down

Analysts cutting estimates

Estimate drift

0.12

Change in 30 days

ROE

-683.0%

ROA-110.2%

Growth

Beta2.18